The cell line K-562 is avaliable from the ATCC. It is a human
erythroleukemic line and acts as an effective NK target.
Jonathan Skipper js6g at virginia.edu
--
Craig L. Slingluff, Jr., M.D.
Associate Professor of Surgery
Chief, Division of Surgical Oncology
University of Virginia Health Sciences Center
cls8h at virginia.edu ph:(804)924-1505 fax:(804)982-1024